Search For "cova"
Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids ab
Updated : 4 years, 2 months ago IST
New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
Read More
COVAX targets 70 pc COVID-19 immunization coverage by mid-2022
Updated : 4 years, 2 months ago IST
Geneva [Switzerland], December 24 (ANI): Amid possible need for variant-specific vaccines, changes to vaccination policies, country preference for some products over others, the programmatic complexity of managing multiple products, and the need for better intelligence on country-level plann
Read More
US to provide additional one million COVID-19 vaccine doses to Afghanistan
Updated : 4 years, 2 months ago IST
Washington [US], December 23 (ANI): US Secretary of State Antony Blinken on Wednesday (local time) said that the United States will work with the international community to scale up the level of assistance provided to Afghanistan, adding to provide one million additional COVID-19 vaccine dos
Read More
Bharat Biotech Chairman meets Vietnam Dy Health Min, discusses Covaxin COV
Updated : 4 years, 2 months ago IST
New Delhi [India], December 18 (ANI): Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with Suchitra Ella Joint Managing Director, Bharat Biotech, met Professor, Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delh
Read More
Israel to donate one million COVID-19 vaccine doses to African countries t
Updated : 4 years, 2 months ago IST
Tel Aviv [Israel], December 17 (ANI): In the coming weeks, the State of Israel will transfer one million Astra Zenica COVID-19 vaccine doses to African countries through the International Covax Vaccine Distribution Mechanism.
Read More
Bharat Biotech donates 2 lakh Covaxin doses to Vietnam
Updated : 4 years, 2 months ago IST
New Delhi [India], December 16 (ANI): Hyderabad-based biotechnology company Bharat Biotech on Thursday announced that it will donate two lakh doses of its COVID-19 vaccine Covaxin to Vietnam.
Read More
Nepal receives 19,65,600 doses of Moderna vaccine under COVAX facility
Updated : 4 years, 3 months ago IST
Kathmandu [Nepal], December 12 (ANI): Nepal on Sunday received 19,65,600 doses of Moderna vaccine from the COVAX facility, the third consignment and part of the 37,12,000 doses of the American vaccine committed by the facility, reported local media.
Read More
COVID-19 vaccination for children: CDSCO approved ZyCoV-D for restricted u
Updated : 4 years, 3 months ago IST
New Delhi [India], November 30 (ANI): The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health an
Read More
Covaxin for 2-18 yrs: Centre examining Expert Committee recommendations, i
Updated : 4 years, 3 months ago IST
New Delhi [India], November 30 (ANI): The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in an emergency situation subject to various cond
Read More
Serum Institute of India resumes exports of COVID-19 vaccine under COVAX p
Updated : 4 years, 3 months ago IST
Pune (Maharashtra) [India], November 26 (ANI): Serum Institute of India (SII) on Friday resumed the exports of its COVID-19 vaccine 'Covishield' to the international COVID vaccine sharing programme COVAX.
Read More
Lancet Infectious Diseases study compare well with phase 3 clinical trials
Updated : 4 years, 3 months ago IST
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
Read More
Covaxin 50 pc effective against symptomatic COVID: Lancet study
Updated : 4 years, 3 months ago IST
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
Read More